Alessandra Ricciardi Selected Research

Helminth Proteins

1/2021

House dust mite sensitization drives cross-reactive immune responses to homologous helminth proteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandra Ricciardi Research Topics

Disease

7	Infections 01/2021 - 01/2015
5	Schistosomiasis (Bilharziasis) 01/2020 - 01/2015
4	COVID-19 08/2022 - 11/2020
2	Neoplasms (Cancer) 04/2021 - 01/2017
2	Inflammation (Inflammations) 01/2021 - 01/2019
2	Pneumonia (Pneumonitis) 01/2021 - 01/2017
2	Parasitic Diseases (Parasitic Disease) 03/2016 - 01/2015
1	Respiratory Insufficiency (Respiratory Failure) 07/2022
1	Opportunistic Infections (Opportunistic Infection) 07/2022
1	Breast Neoplasms (Breast Cancer) 02/2022
1	Asthma (Bronchial Asthma) 11/2021
1	Crohn Disease (Crohn's Disease) 04/2021
1	Immediate Hypersensitivity 01/2021
1	Loiasis 01/2021
1	Eosinophilia 12/2020
1	Strongyloidiasis 12/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2020
1	Schistosomiasis mansoni 01/2020
1	Pruritus (Itching) 08/2019
1	Rheumatoid Arthritis 08/2019
1	Hepatitis E 08/2019
1	Hepatitis 08/2019
1	Fatigue 08/2019
1	Ascariasis 01/2019
1	HIV Infections (HIV Infection) 01/2017
1	Lung Diseases (Lung Disease) 01/2017
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2016
1	Hepatitis B 08/2012
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2011

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 02/2022 - 10/2011
4	Cathepsin BIBA 01/2020 - 01/2015
2	BNT162 VaccineIBA 02/2022 - 11/2021
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 12/2020
2	Interleukin-13IBA 01/2021 - 01/2019
2	AntigensIBA 01/2021 - 01/2021
1	remdesivirIBA 08/2022
1	Neutralizing AntibodiesIBA 02/2022
1	Monoclonal AntibodiesIBA 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	mepolizumabIBA 11/2021
1	Biological ProductsIBA 11/2021
1	COVID-19 VaccinesIBA 11/2021
1	fibroblast activation protein alphaIBA 04/2021
1	neutravidinIBA 04/2021
1	Biotin (Vitamin H)FDA Link 04/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	AllergensIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	AntibodiesIBA 01/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	TropomyosinIBA 01/2021
1	Helminth ProteinsIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Interleukin-5 (Interleukin 5)IBA 01/2021
1	CytokinesIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Interleukin-9 (Interleukin 9)IBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	Fatty Acid-Binding ProteinsIBA 12/2020
1	Eosinophil Granule ProteinsIBA 12/2020
1	Oxygen (Dioxygen)IBA 11/2020
1	sulfated lactosyl archaeolIBA 01/2020
1	EnzymesIBA 08/2019
1	RNA (Ribonucleic Acid)IBA 08/2019
1	SteroidsIBA 08/2019
1	Leflunomide (Arava)FDA LinkGeneric 08/2019
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2017
1	mannide monooleateIBA 03/2016
1	Monatide (IMS 3015)IBA 03/2016
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2015
1	Praziquantel (Biltricide)FDA Link 01/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	Rituximab (Mabthera)FDA Link 08/2012
1	DNA (Deoxyribonucleic Acid)IBA 08/2012
1	Lamivudine (Epivir)FDA Link 08/2012
1	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2011

Therapy/Procedure

2	Therapeutics 08/2019 - 03/2016
1	Lung Transplantation 07/2022
1	Length of Stay 07/2022
1	Stem Cell Transplantation 01/2017
1	Art Therapy 03/2016